Canada markets close in 3 hours 43 minutes

Numinus Wellness Inc. (NUMI.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.7700-0.0400 (-4.94%)
As of 12:14PM EDT. Market open.
Full screen
Previous Close0.8100
Open0.8200
Bid0.7700 x N/A
Ask0.7800 x N/A
Day's Range0.7700 - 0.8200
52 Week Range0.2200 - 2.4500
Volume294,910
Avg. Volume700,060
Market Cap154.826M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.1040
Earnings DateApr. 29, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    Numinus to Participate in Upcoming Investor Conferences in September 2021

    Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced that it will participate in two upcoming investor conferences:

  • Newsfile

    CORRECTION FROM SOURCE: BTV Examines the Rapidly Expanding Psychedelics Market

    Vancouver, British Columbia--(Newsfile Corp. - August 17, 2021) - On Sun. Aug. 22nd at 5pm EST broadcast on FOX Business News — BTV-Business Television explores the burgeoning sector that has captured the attention of investors - psychedelics.Cannot view this video? Visit:https://b-tv.com/btv-examines-the-rapidly-expanding-psychedelics-market-ep-362/Discover Companies to Invest In - Click company name to watch their TV feature: Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) — Researching an

  • Newsfile

    BTV Examines the Rapidly Expanding Psychedelics Market

    Vancouver, British Columbia--(Newsfile Corp. - August 17, 2021) - On Sun. Aug. 22nd at 5pm EST broadcast on FOX Business News — BTV-Business Television explores the burgeoning sector that has captured the attention of investors - psychedelics.Cannot view this video? Visit:https://b-tv.com/btv-examines-the-rapidly-expanding-psychedelics-market-ep-362/Discover Companies to Invest In - Click company name to watch their TV feature: Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) — Researching an